The Clorox Company (CLX)
NYSE: CLX · Real-Time Price · USD
105.70
-0.84 (-0.79%)
Aug 14, 2026, 4:00 PM EDT - Market closed
The Clorox Company Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 6,720 | 7,104 | 7,093 | 7,389 | 7,107 | |
Revenue Growth | -5.41% | 0.15% | -4.01% | 3.97% | -3.19% |
Cost of Revenue | 3,876 | 3,896 | 4,028 | 4,484 | 4,562 |
Gross Profit | 2,844 | 3,208 | 3,065 | 2,905 | 2,545 |
Selling, General & Admin | 1,819 | 1,896 | 1,985 | 1,921 | 1,679 |
Research & Development | 116 | 121 | 126 | 139 | 132 |
Other Operating Expenses | 20 | 6 | 33 | 33 | 22 |
Operating Expenses | 1,955 | 2,023 | 2,144 | 2,093 | 1,833 |
Operating Income | 889 | 1,185 | 921 | 812 | 712 |
Interest Expense | -130 | -88 | -90 | -90 | -106 |
Interest & Investment Income | 8 | 9 | 23 | 16 | 5 |
Earnings From Equity Investments | 3 | 4 | 5 | 4 | 6 |
Currency Exchange Gain (Loss) | -4 | -2 | -25 | -13 | -3 |
EBT Excluding Unusual Items | 766 | 1,108 | 834 | 729 | 614 |
Merger & Restructuring Charges | - | - | -32 | -60 | - |
Gain (Loss) on Sale of Investments | 25 | 18 | 20 | 14 | -21 |
Gain (Loss) on Sale of Assets | - | -118 | -224 | - | 14 |
Asset Writedown | - | - | - | -445 | - |
Other Unusual Items | - | - | -200 | - | - |
Pretax Income | 791 | 1,078 | 398 | 238 | 607 |
Income Tax Expense | 190 | 254 | 106 | 77 | 136 |
Earnings From Continuing Operations | 601 | 824 | 292 | 161 | 471 |
Net Income to Company | 601 | 824 | 292 | 161 | 471 |
Minority Interest in Earnings | -14 | -14 | -12 | -12 | -9 |
Net Income | 587 | 810 | 280 | 149 | 462 |
Net Income to Common | 587 | 810 | 280 | 149 | 462 |
Net Income Growth | -27.53% | 189.29% | 87.92% | -67.75% | -34.93% |
Shares Outstanding (Basic) | 122 | 124 | 124 | 124 | 123 |
Shares Outstanding (Diluted) | 122 | 124 | 125 | 124 | 124 |
Shares Change | -1.73% | -0.41% | 0.50% | 0.22% | -2.67% |
EPS (Basic) | 4.82 | 6.56 | 2.25 | 1.21 | 3.75 |
EPS (Diluted) | 4.81 | 6.52 | 2.25 | 1.20 | 3.73 |
EPS Growth | -26.23% | 189.78% | 87.50% | -67.83% | -33.15% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 405 | 761 | 483 | 930 | 535 |
Free Cash Flow Per Share | 3.32 | 6.12 | 3.87 | 7.49 | 4.32 |
Dividend Per Share | 4.970 | 4.900 | 4.820 | 4.740 | 4.660 |
Dividend Growth | 1.43% | 1.66% | 1.69% | 1.72% | 3.79% |
Gross Margin | 42.32% | 45.16% | 43.21% | 39.31% | 35.81% |
Operating Margin | 13.23% | 16.68% | 12.98% | 10.99% | 10.02% |
Profit Margin | 8.73% | 11.40% | 3.95% | 2.02% | 6.50% |
Free Cash Flow Margin | 6.03% | 10.71% | 6.81% | 12.59% | 7.53% |
EBITDA | 1,140 | 1,412 | 1,157 | 1,038 | 928 |
EBITDA Margin | 16.96% | 19.88% | 16.31% | 14.05% | 13.06% |
D&A For EBITDA | 251 | 227 | 236 | 226 | 216 |
EBIT | 889 | 1,185 | 921 | 812 | 712 |
EBIT Margin | 13.23% | 16.68% | 12.98% | 10.99% | 10.02% |
Effective Tax Rate | 24.02% | 23.56% | 26.63% | 32.35% | 22.41% |
Advertising Expenses | 749 | 770 | 832 | 734 | 709 |